Biernacki, M.; Łuczaj, W.; Jarocka-Karpowicz, I.; Ambrożewicz, E.; Toczek, M.; Skrzydlewska, E.
The Effect of Long-Term Administration of Fatty Acid Amide Hydrolase Inhibitor URB597 on Oxidative Metabolism in the Heart of Rats with Primary and Secondary Hypertension. Molecules 2018, 23, 2350.
https://doi.org/10.3390/molecules23092350
AMA Style
Biernacki M, Łuczaj W, Jarocka-Karpowicz I, Ambrożewicz E, Toczek M, Skrzydlewska E.
The Effect of Long-Term Administration of Fatty Acid Amide Hydrolase Inhibitor URB597 on Oxidative Metabolism in the Heart of Rats with Primary and Secondary Hypertension. Molecules. 2018; 23(9):2350.
https://doi.org/10.3390/molecules23092350
Chicago/Turabian Style
Biernacki, Michał, Wojciech Łuczaj, Iwona Jarocka-Karpowicz, Ewa Ambrożewicz, Marek Toczek, and Elżbieta Skrzydlewska.
2018. "The Effect of Long-Term Administration of Fatty Acid Amide Hydrolase Inhibitor URB597 on Oxidative Metabolism in the Heart of Rats with Primary and Secondary Hypertension" Molecules 23, no. 9: 2350.
https://doi.org/10.3390/molecules23092350
APA Style
Biernacki, M., Łuczaj, W., Jarocka-Karpowicz, I., Ambrożewicz, E., Toczek, M., & Skrzydlewska, E.
(2018). The Effect of Long-Term Administration of Fatty Acid Amide Hydrolase Inhibitor URB597 on Oxidative Metabolism in the Heart of Rats with Primary and Secondary Hypertension. Molecules, 23(9), 2350.
https://doi.org/10.3390/molecules23092350